Elizabeth Harford‐Wright

649 total citations
20 papers, 494 citations indexed

About

Elizabeth Harford‐Wright is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Elizabeth Harford‐Wright has authored 20 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 6 papers in Genetics. Recurrent topics in Elizabeth Harford‐Wright's work include Glioma Diagnosis and Treatment (6 papers), Cancer, Stress, Anesthesia, and Immune Response (6 papers) and Brain Metastases and Treatment (4 papers). Elizabeth Harford‐Wright is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Cancer, Stress, Anesthesia, and Immune Response (6 papers) and Brain Metastases and Treatment (4 papers). Elizabeth Harford‐Wright collaborates with scholars based in Australia, France and United Kingdom. Elizabeth Harford‐Wright's co-authors include Robert Vink, Julie Gavard, M. N. Ghabriel, Nicolas Bidère, Lucas Treps, Emma Thornton, Alain Schmitt, Damien Ricard, Eva María Galán‐Moya and Kathryn Jacobs and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and PLoS ONE.

In The Last Decade

Elizabeth Harford‐Wright

20 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Harford‐Wright Australia 12 248 145 95 77 65 20 494
Hans‐Peter Jüsten Germany 8 142 0.6× 91 0.6× 42 0.4× 29 0.4× 38 0.6× 12 469
Ayami Kondo Japan 12 230 0.9× 97 0.7× 44 0.5× 33 0.4× 28 0.4× 20 468
Daniela Maria Rasà Italy 13 152 0.6× 139 1.0× 42 0.4× 16 0.2× 29 0.4× 17 347
Dianer Yang United States 14 229 0.9× 53 0.4× 97 1.0× 52 0.7× 12 0.2× 16 562
Virginie Firlej France 13 576 2.3× 194 1.3× 191 2.0× 14 0.2× 148 2.3× 26 968
David Bargiela United Kingdom 17 412 1.7× 150 1.0× 173 1.8× 17 0.2× 42 0.6× 30 855
Jianhua Su China 12 282 1.1× 88 0.6× 181 1.9× 26 0.3× 9 0.1× 32 536
J. M. Kros Netherlands 8 229 0.9× 46 0.3× 55 0.6× 22 0.3× 54 0.8× 11 486
Ezequiel Surace Argentina 16 294 1.2× 90 0.6× 23 0.2× 20 0.3× 90 1.4× 40 723

Countries citing papers authored by Elizabeth Harford‐Wright

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Harford‐Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Harford‐Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Harford‐Wright more than expected).

Fields of papers citing papers by Elizabeth Harford‐Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Harford‐Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Harford‐Wright. The network helps show where Elizabeth Harford‐Wright may publish in the future.

Co-authorship network of co-authors of Elizabeth Harford‐Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Harford‐Wright. A scholar is included among the top collaborators of Elizabeth Harford‐Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Harford‐Wright. Elizabeth Harford‐Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emmenis, Lucie Van, Elizabeth Harford‐Wright, Anne-Laure Cattin, et al.. (2025). Identification of CCL3 as a Schwann cell chemotactic factor essential for nerve regeneration. Cell Reports. 44(2). 115322–115322. 2 indexed citations
2.
3.
Jacobs, Kathryn, Gwennan André‐Grégoire, Ying Li, et al.. (2019). Paracaspase MALT1 regulates glioma cell survival by controlling endo‐lysosome homeostasis. The EMBO Journal. 39(1). e102030–e102030. 36 indexed citations
4.
Rosenberg, Laura H., Anne-Laure Cattin, Xavier Fontana, et al.. (2018). HDAC3 Regulates the Transition to the Homeostatic Myelinating Schwann Cell State. Cell Reports. 25(10). 2755–2765.e5. 28 indexed citations
5.
Harford‐Wright, Elizabeth & Julie Gavard. (2018). Apelin, the Devil Inside Brain Tumors. SHILAP Revista de lepidopterología. 12. 2211759872–2211759872. 11 indexed citations
6.
Harford‐Wright, Elizabeth, Gwennan André‐Grégoire, Kathryn Jacobs, et al.. (2017). Pharmacological targeting of apelin impairs glioblastoma growth. Brain. 140(11). 2939–2954. 70 indexed citations
7.
Harford‐Wright, Elizabeth, Nicolas Bidère, & Julie Gavard. (2016). β-escin selectively targets the glioblastoma-initiating cell population and reduces cell viability. Oncotarget. 7(41). 66865–66879. 22 indexed citations
8.
Treps, Lucas, Elizabeth Harford‐Wright, Eva María Galán‐Moya, et al.. (2015). Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma. Oncogene. 35(20). 2615–2623. 94 indexed citations
9.
Azzi, Sandy, et al.. (2015). Desert Hedgehog/Patch2 Axis Contributes to Vascular Permeability and Angiogenesis in Glioblastoma. Frontiers in Pharmacology. 6. 281–281. 16 indexed citations
10.
11.
Giacci, Marcus K., Bernadette T. Majda, Carole A. Bartlett, et al.. (2014). Differential Effects of 670 and 830 nm Red near Infrared Irradiation Therapy: A Comparative Study of Optic Nerve Injury, Retinal Degeneration, Traumatic Brain and Spinal Cord Injury. PLoS ONE. 9(8). e104565–e104565. 52 indexed citations
12.
Harford‐Wright, Elizabeth, et al.. (2014). Evaluating the role of substance P in the growth of brain tumors. Neuroscience. 261. 85–94. 22 indexed citations
13.
Harford‐Wright, Elizabeth, et al.. (2014). Treatment with the NK1 Antagonist Emend Reduces Blood Brain Barrier Dysfunction and Edema Formation in an Experimental Model of Brain Tumors. PLoS ONE. 9(5). e97002–e97002. 21 indexed citations
14.
Harford‐Wright, Elizabeth, et al.. (2013). NK1 receptor antagonists and dexamethasone as anticancer agents in vitro and in a model of brain tumours secondary to breast cancer. Anti-Cancer Drugs. 24(4). 344–354. 14 indexed citations
15.
Harford‐Wright, Elizabeth, et al.. (2013). The Potential for Substance P Antagonists as Anti-Cancer Agents in Brain Tumours. PubMed. 8(1). 13–23. 8 indexed citations
16.
Harford‐Wright, Elizabeth, et al.. (2013). Characterisation of Walker 256 breast carcinoma cells from two tumour cell banks as assessed using two models of secondary brain tumours. Cancer Cell International. 13(1). 5–5. 11 indexed citations
17.
Harford‐Wright, Elizabeth, et al.. (2012). Walker 256 tumour cells increase substance P immunoreactivity locally and modify the properties of the blood–brain barrier during extravasation and brain invasion. Clinical & Experimental Metastasis. 30(1). 1–12. 25 indexed citations
18.
Harford‐Wright, Elizabeth, et al.. (2012). Targeting classical but not neurogenic inflammation reduces peritumoral oedema in secondary brain tumours. Journal of Neuroimmunology. 250(1-2). 59–65. 7 indexed citations
19.
Harford‐Wright, Elizabeth, et al.. (2010). Towards Drug Discovery for Brain Tumours: Interaction of Kinins and Tumours at the Blood Brain Barrier Interface. PubMed. 6(1). 31–40. 7 indexed citations
20.
Harford‐Wright, Elizabeth, Emma Thornton, & Robert Vink. (2010). Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury. Neuroscience Letters. 481(1). 26–29. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans‐Peter Jüsten Breakdown of academic impact, for papers by Ayami Kondo Breakdown of academic impact, for papers by Daniela Maria Rasà Breakdown of academic impact, for papers by Dianer Yang Breakdown of academic impact, for papers by Virginie Firlej Breakdown of academic impact, for papers by David Bargiela Breakdown of academic impact, for papers by Jianhua Su Breakdown of academic impact, for papers by J. M. Kros Breakdown of academic impact, for papers by Ezequiel Surace
Rankless by CCL
2026